Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial

VM Rantalaiho; H Kautiainen; M Korpela; PJ Hannonen; M Leirisalo-Repo; T Möttönen

doi:10.1136/annrheumdis-2012-202737

Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial

VM Rantalaiho, H Kautiainen, M Korpela, PJ Hannonen, M Leirisalo-Repo, T Möttönen

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

1 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	786-788
Julkaisu	ANNALS OF THE RHEUMATIC DISEASES
Vuosikerta	72
Numero	5
DOI - pysyväislinkit	https://doi.org/10.1136/annrheumdis-2012-202737
Tila	Julkaistu - 2013
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Julkaisufoorumi-taso

Ei tasoa

Pääsy asiakirjaan

10.1136/annrheumdis-2012-202737

Siteeraa tätä

Rantalaiho, VM., Kautiainen, H., Korpela, M., Hannonen, PJ., Leirisalo-Repo, M., & Möttönen, T. (2013). Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial. ANNALS OF THE RHEUMATIC DISEASES, 72(5), 786-788. https://doi.org/10.1136/annrheumdis-2012-202737

@article{804098ae4e4841e3a5e9c9c0f576cb58,

title = "Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial",

author = "VM Rantalaiho and H Kautiainen and M Korpela and PJ Hannonen and M Leirisalo-Repo and T M{\"o}tt{\"o}nen",

year = "2013",

doi = "10.1136/annrheumdis-2012-202737",

language = "English",

volume = "72",

pages = "786--788",

journal = "ANNALS OF THE RHEUMATIC DISEASES",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "5",

}

Rantalaiho, VM, Kautiainen, H, Korpela, M, Hannonen, PJ, Leirisalo-Repo, M & Möttönen, T 2013, 'Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial', ANNALS OF THE RHEUMATIC DISEASES, Vuosikerta 72, Nro 5, Sivut 786-788. https://doi.org/10.1136/annrheumdis-2012-202737

Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial. / Rantalaiho, VM; Kautiainen, H; Korpela, M et al.
julkaisussa: ANNALS OF THE RHEUMATIC DISEASES, Vuosikerta 72, Nro 5, 2013, s. 786-788.

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial

AU - Rantalaiho, VM

AU - Kautiainen, H

AU - Korpela, M

AU - Hannonen, PJ

AU - Leirisalo-Repo, M

AU - Möttönen, T

PY - 2013

Y1 - 2013

U2 - 10.1136/annrheumdis-2012-202737

DO - 10.1136/annrheumdis-2012-202737

M3 - Article

SN - 0003-4967

VL - 72

SP - 786

EP - 788

JO - ANNALS OF THE RHEUMATIC DISEASES

JF - ANNALS OF THE RHEUMATIC DISEASES

IS - 5

ER -